XHC:CA:TSX-iShares Global Healthcare (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 75.01

Change

-0.17 (-0.23)%

Market Cap

CAD 0.65B

Volume

1.71K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.70 (-1.74%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

+0.02 (+0.18%)

CAD 1.94B
XIT:CA iShares S&P/TSX Capped Informa..

-0.93 (-1.60%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

-0.42 (-1.94%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

-0.31 (-1.66%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.07 (+0.31%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

-0.20 (-0.33%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.01 (+0.03%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

+0.15 (+0.24%)

CAD 0.28B
ZUH:CA BMO Equal Weight US Health Car..

-0.83 (-1.13%)

CAD 0.27B

ETFs Containing XHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.48% 80% B- 55% F
Dividend Return 0.56% 35% F 17% F
Total Return 13.04% 60% D- 51% F
Trailing 12 Months  
Capital Gain 16.29% 37% F 43% F
Dividend Return 2.47% 61% D- 42% F
Total Return 18.77% 37% F 44% F
Trailing 5 Years  
Capital Gain 58.68% 60% D- 72% C
Dividend Return 7.04% 52% F 24% F
Total Return 65.72% 63% D 72% C
Average Annual (5 Year Horizon)  
Capital Gain 7.63% N/A N/A 63% D
Dividend Return 8.69% N/A N/A 62% D
Total Return 1.05% N/A N/A 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.58% N/A N/A 85% B
Risk Adjusted Return 101.23% N/A N/A 97% N/A
Market Capitalization 0.65B 94% A 63% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.